You are here

  • Home
  • Archive
  • Volume 3, Issue Suppl 1
  • Pilot trial of a type I - polarized autologous dendritic cell vaccine incorporating tumor blood vessel antigen-derived peptides in patients with metastatic breast cancer

Article metrics

Article menu

Download PDFPDF

Poster Presentation
Pilot trial of a type I - polarized autologous dendritic cell vaccine incorporating tumor blood vessel antigen-derived peptides in patients with metastatic breast cancer

 

Online download statistics by month:

Online download statistics by month: December 2019 to September 2025

AbstractFullPdf
Dec 2019020
Jan 2020031
Feb 2020031
May 2020082
Jun 2020090
Jul 2020030
Aug 2020021
Sep 2020050
Oct 2020021
Nov 2020020
Dec 2020033
Jan 2021010
Feb 2021010
Mar 2021020
Apr 2021020
May 2021011
Jul 2021041
Aug 2021032
Sep 2021020
Oct 2021031
Nov 2021053
Dec 2021061
Jan 2022030
Feb 2022010
Mar 2022020
Apr 2022041
May 2022031
Jun 2022030
Jul 2022050
Aug 2022061
Sep 2022051
Oct 2022041
Nov 20220121
Dec 2022070
Jan 2023052
Feb 2023010
Mar 2023024
Apr 2023017
May 2023020
Jun 2023021
Jul 2023056
Aug 2023002
Sep 2023010
Oct 2023052
Nov 2023041
Dec 2023053
Jan 2024020
Feb 20240102
Mar 20240737
Apr 2024057
May 20240101
Jun 2024083
Jul 20240112
Aug 2024053
Sep 2024054
Oct 20240145
Nov 20240163
Dec 20240172
Jan 2025074
Feb 2025032
Mar 2025060
Apr 20250162
May 2025066
Jun 20250104
Jul 2025010
Aug 2025020
Sep 2025020
Total0323139